Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 1 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung CancerNot yet recruitingNCT07896005Phase 3
• SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III StudyNot yet recruitingNCT07895992Phase 3
• A Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast CancerNot yet recruitingNCT07894328Phase 3
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy ParticipantsNot yet recruitingNCT07889349Phase 1
• A Drug-Drug Interaction Study of Rifampicin and Oral HRS-8080Not yet recruitingNCT07876596Phase 1
• A Trial of RLX-2508-102 in Healthy VolunteersNot yet recruitingNCT07873671Early Phase 1
• An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.Not yet recruitingNCT07863167Phase 2
• A Study of HRS-4729 Injection in Participants With Type 2 DiabetesNot yet recruitingNCT07843862Phase 2
• A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple DosesNot yet recruitingNCT07841860Phase 1
• A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerability and PharmacokineticsNot yet recruitingNCT07830199Phase 1
• A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With ObesityNot yet recruitingNCT07826364Phase 1
• Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 StudyNot yet recruitingNCT07808918Phase 1
• A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal ImpairmentRecruitingNCT07807059Phase 1
• An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid TumorsRecruitingNCT07806058Phase 1/2
• A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy ParticipantsRecruitingNCT07802964Phase 1
• A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With HypertriglyceridemiaRecruitingNCT07799688Phase 2
• A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLCRecruitingNCT07798947Phase 2
• A Global Trial of Trastuzumab Rezetecan (SHR-A1811) in Combination With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Colorectal Cancer Expressing HER2Not yet recruitingNCT07796763Phase 2
• FH-006 Versus Investigator's Choice of Chemotherapy in Patients With Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma Who Have Failed Prior PD-1/PD-L1 Inhibitor Combined With Platinum-Based Chemotherapy.Not yet recruitingNCT07790380Phase 3
• Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian CancerNot yet recruitingNCT07779538Phase 3
• Phase I/II Clinical Trials of SHR-8203 Injection in Participants With Advanced Solid TumorsNot yet recruitingNCT07769242Phase 1/2
• Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular EventsNot yet recruitingNCT07767513Phase 2
• A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative ColitisNot yet recruitingNCT07760831Phase 1
• A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel DiseaseRecruitingNCT07758101Phase 1
• A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque PsoriasisNot yet recruitingNCT07758075Phase 2
• Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy ParticipantsNot yet recruitingNCT07752069Phase 1
• A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT07751341Phase 2
• A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy AdultsRecruitingNCT07749651Phase 1
• Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in AdultsRecruitingNCT07746726Phase 3
• The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke PatientsNot yet recruitingNCT07739160Phase 2
• A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate CancerRecruitingNCT07735377Phase 1
• A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBCRecruitingNCT07726992Phase 3
• Phase II Clinical Trial of SHR-1139 Injection in Patients With PsoriasisRecruitingNCT07719530Phase 2
• A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate CancerRecruitingNCT07711184Phase 1
• A Trial of Ribupatide Injection in Participants With Obesity and Knee OsteoarthritisNot yet recruitingNCT07709910Phase 3
• A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and VomitingRecruitingNCT07709897Phase 2
• A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.RecruitingNCT07708441Phase 2/3
• Clinical Study of HRS-2129 for Acute Gouty ArthritisRecruitingNCT07706777Phase 2
• The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung CancerNot yet recruitingNCT07704645Phase 2
• A Study Comparing a Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy ParticipantsNot yet recruitingNCT07701239Phase 1
• A Clinical Study of HRS-8797 in Healthy ParticipantsNot yet recruitingNCT07698756Phase 1
• Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 TabletNot yet recruitingNCT07696091Phase 1
• A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular CarcinomaNot yet recruitingNCT07691762Phase 3
• A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in ObesityNot yet recruitingNCT07690826Phase 2
• A Trial of HRS-3095 in Healthy VolunteersRecruitingNCT07686484Early Phase 1
• A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular CarcinomaNot yet recruitingNCT07682272Phase 2
• A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast CancerRecruitingNCT07679360Phase 3
• A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid TumorsRecruitingNCT07676903Phase 1
• A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal CancerRecruitingNCT07676162Phase 3
• A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese SubjectsRecruitingNCT07670884Phase 3
• A Clinical Study of SHR-3079 in B-cell Non-Hodgkin LymphomaRecruitingNCT07661537Phase 1
• A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated SteatohepatitisRecruitingNCT07660848Phase 2
• Human Mass Balance Study of [¹⁴C]HRS-1893Not yet recruitingNCT07656779Phase 1
• A Clinical Study of SHR-5421 in Patients With Multiple MyelomaRecruitingNCT07652281Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07640451Phase 2
• Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney DiseaseNot yet recruitingNCT07625774Phase 3
• A Phase II Study of SHR-2173 Injection in Patients With Myasthenia GravisRecruitingNCT07622342Phase 2
• A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous UrticariaNot yet recruitingNCT07613866Phase 2
• Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis BRecruitingNCT07606950Phase 3
• A Clinical Study of HRS-7156 in Healthy ParticipantsRecruitingNCT07601087Phase 1
• A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard TreatmentNot yet recruitingNCT07601048Phase 3
• A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes MellitusRecruitingNCT07599410Phase 2
• An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic CancerRecruitingNCT07589569Phase 2
• Phase I Study of HRS-1635 in B-cell MalignanciesRecruitingNCT07583212Phase 1
• A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA NephropathyRecruitingNCT07582133Phase 2
• A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPDRecruitingNCT07567872Phase 1
• A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male SubjectsNot yet recruitingNCT07557407Phase 1
• Phase I Study of HRS-3005 in B-cell MalignanciesRecruitingNCT07556822Phase 1
• A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular DiseaseRecruitingNCT07551492Phase 3
• A Clinical Study of HRS-5765 in Healthy ParticipantsRecruitingNCT07551167Phase 1
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.Not yet recruitingNCT07543224Phase 3
• A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic FunctionRecruitingNCT07540754Phase 1
• Phase III Study of HRS-7535 for Hypertension With Overweight or ObesityRecruitingNCT07528027Phase 3
• Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction CancerRecruitingNCT07522151Phase 3
• A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast CancerRecruitingNCT07497386Phase 2
• A Phase I Study of SHR-3836 in Patients With Multiple MyelomaRecruitingNCT07490613Phase 1
• A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung CancerRecruitingNCT07489716Phase 2
• A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 InjectionRecruitingNCT07489482Phase 1
• A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT07478302Phase 1
• A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal CancerRecruitingNCT07454720Phase 2/3
• A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract CancerRecruitingNCT07450976Phase 2
• A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor SubjectsRecruitingNCT07446153Phase 1/2
• A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma GangrenosumNot yet recruitingNCT07444684Phase 2
• A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBCRecruitingNCT07424287Phase 3
• A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney DiseaseRecruitingNCT07419828Phase 3
• A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical CancerRecruitingNCT07418749Phase 3
• A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy SubjectsRecruitingNCT07414602Phase 1
• A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate CancerRecruitingNCT07407283Phase 1/2
• A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 InhibitorsRecruitingNCT07404553Phase 2/3
• A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial CarcinomaRecruitingNCT07393542Phase 3
• A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast CancerRecruitingNCT07389733Phase 1/2
• A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid TumorsRecruitingNCT07380334Phase 1
• A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic PainRecruitingNCT07377721Phase 1
• The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and HyperuricemiaRecruitingNCT07362355Phase 2
• A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative CancerRecruitingNCT07358377Phase 1
• A Study of SHR-2173 in Participants With Primary IgA NephropathyRecruitingNCT07354932Phase 2
• A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.RecruitingNCT07354022Phase 3
• A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary DiseaseRecruitingNCT07349524Phase 2
• A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast CancerRecruitingNCT07349069Phase 3
• Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid RetentionRecruitingNCT07318103Phase 2

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas